Catatan efek · kuartal yang diarsipkan
VRTX
Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
19Pemegang yang dilacak
0Δ pemegang
46.24MSaham yang dipegang
$21.49BNilai yang dilaporkan
+0Posisi baru
−0Keluar
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -0.5% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2024
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | -1 | 212.02M | $105.17B | +5 | −5 |
| Q1 2026 | 178 | 0 | 208.95M | $93.29B | +5 | −6 |
| Q4 2025 | 177 | -1 | 219.78M | $99.62B | +2 | −2 |
| Q3 2025 | 26 | +1 | 120.93M | $47.35B | +1 | −1 |
| Q2 2025 | 23 | +1 | 112.15M | $49.92B | +3 | −2 |
| Q1 2025 | 19 | -2 | 60.41M | $29.28B | — | −2 |
| Q4 2024 | 21 | +1 | 60.08M | $24.19B | +1 | — |
| Q3 2024 | 19 | 0 | 46.24M | $21.49B | — | — |
| Q2 2024 | 19 | — | 46.47M | $21.77B | — | — |
Siapa yang memegangnya · Q3 2024
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 26.81M | +0.4% | $12.47B | 1.9% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasif) | 5.94M | -6.2% | $2.75B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasif) | 5.94M | -6.2% | $2.75B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 12 | Norges Bank ✦ (pasif) | 3.41M | -0.6% | $1.59B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 1.77M | -20.1% | $822.27M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 1.77M | -20.1% | $822.27M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 1.63M | +4.2% | $758.77M | 1.1% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 480.86K | -10.3% | $223.12M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 480.86K | -10.3% | $223.12M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 480.86K | -10.3% | $223.12M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 19 | Adage Capital Partners ✦ | 346.36K | +3.3% | $161.08M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 20 | Marshall Wace ✦ | 244.00K | +92.1% | $113.48M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 160.53K | -51.6% | $74.66M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 22 | Millennium Management ✦ | 159.29K | +11.6% | $74.08M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 23 | Baillie Gifford ✦ | 140.58K | -16.1% | $65.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Baillie Gifford ✦ | 140.58K | -16.1% | $65.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | Baillie Gifford ✦ | 140.58K | -16.1% | $65.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | Baillie Gifford ✦ | 140.58K | -16.1% | $65.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 138.41K | -18.6% | $64.37M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 138.41K | -18.6% | $64.37M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 29 | Tweedy, Browne ✦ | 53.60K | -1.4% | $24.93M | 1.2% | ▼ Trim | 2 | SEC ↗ |
| 30 | ARK Investment Management ✦ | 51.10K | -32.3% | $23.76M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 50.23K | -52.0% | $23.36M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 50.23K | -52.0% | $23.36M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 33 | Gotham Asset Management ✦ | 27.13K | +9.8% | $12.62M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 34 | Fisher Asset Management ✦ | 27.02K | -3.9% | $12.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | Bridgewater Associates ✦ | 3.45K | -89.6% | $1.61M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1,678 pemegang, 225.07M saham, $98.10B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q3 2024 ·
Metodologi ·
Dapatkan ini melalui API